In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senesco Technologies Inc.

www.senesco.com

Latest From Senesco Technologies Inc.

Deals Shaping The Medical Industry, January 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced November through December 2013

BioPharmaceutical Medical Device

BioNotebook: Threshold earns Merck KGaA payment, Amicus taps financing after dumped by GSK, Senesco to merge with Fabrus

Threshold Pharmaceuticals earned a payment from partner Merck KGaA after hitting a target for enrolling patients in a sarcoma study. A month after being dumped by development partner GlaxoSmithKline, Amicus Therapeutics said it completed debt financing that will help it operate next year.

Cancer Germany

Senesco starts transition from agbio to drug maker with first IND

It's not every day that a company goes from creating a technology that extends the shelf life of bananas to using the same platform approach to try to prolong the lives of patients with multiple myeloma – a disease in which two-thirds of patients are dead within five years.

Immune Disorders Cancer

Deals Shaping the Medical Industry (06/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Senesco Technologies Inc.
  • Senior Management
  • Ronald A Martell, Pres. & CEO
    Joel Brooks, CFO
    John E Thompson, PhD, EVP, R&D
  • Contact Info
  • Senesco Technologies Inc.
    Phone: (908) 864-4444
    721 Route 202/206
    Suite 130
    Bridgewater, NJ 08807
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register